DCF — AKRON GENERAL MEDICAL CENTER
Enterprise Value: $904.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$904.4M
Enterprise Value
$247.0M
PV of Cash Flows
$657.4M
PV of Terminal Value
$1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $797.0M | $108.2M | 14.0% | $52.4M | $47.6M |
| Year 2 | $820.9M | $119.7M | 15.0% | $60.1M | $49.7M |
| Year 3 | $845.6M | $131.7M | 16.0% | $68.3M | $51.3M |
| Year 4 | $870.9M | $140.0M | 16.0% | $73.6M | $50.3M |
| Year 5 | $897.0M | $146.4M | 16.0% | $77.5M | $48.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $904.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$773.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13075683324737541
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5